OR WAIT null SECS
May 30, 2012
Merger is not expected to affect specialty-distribution agreements negatively
Ten-year BLS projection sees a healthy industry ahead
May 24, 2012
March 05, 2012
FDA's draft documents on biosimilar regulation move the prospect one step closer
March 04, 2012
Tompkins International's annual preview of key pharma supply chain issues
Begin thinking of your business as a 'disease' company vs. a 'drug' company
January 08, 2012
With Rx-360 already at critical mass and delivering results, the call is out for more participation
January 07, 2012
The proposed federal National Center for Advancing Translational Sciences holds promise for drug development
November 13, 2011
Specialty distributors, specialty pharmacies and healthcare providers are all competing for a dominant position in drug delivery and reimbursement